Betsy Merrell
Family Medicine · Hendersonville, NCNPI 1265475636
Payments from drug & device makers
Across 165 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$445
- Pfizer$267
- AstraZeneca$254
- Amgen$189
- AbbVie$187
- Lilly USA, LLC$168
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,717100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $445 |
| Pfizer | 20 | $267 |
| AstraZeneca | 14 | $254 |
| Amgen | 12 | $189 |
| AbbVie | 10 | $187 |
| Lilly USA, LLC | 11 | $168 |
| GSK | 10 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $153 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $129 |
| Novartis | 6 | $103 |
| Abbott | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Boehringer Ingelheim | 4 | $67 |
| Kowa Pharmaceuticals America, Inc. | 4 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Johnson & Johnson | 3 | $46 |
| Nevro Corp. | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| IBSA Pharma Inc. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Exact Sciences | 2 | $28 |
| Corium, LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Radius Health, Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$2,718 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 124 | $198,863 |
| EliquisApixaban | 125 | $112,861 |
| XareltoRivaroxaban | 92 | $93,202 |
| RybelsusSemaglutide | 31 | $65,016 |
| MounjaroTirzepatide | 47 | $59,525 |
| FarxigaDapagliflozin Propanediol | 43 | $48,137 |
| JardianceEmpagliflozin | 32 | $46,980 |
| MyrbetriqMirabegron | 40 | $28,377 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $24,892 |
| Tresiba Flextouch U-100Insulin Degludec | 40 | $23,988 |
| LinzessLinaclotide | 15 | $22,448 |
| TrulicityDulaglutide | 19 | $20,171 |
| SynthroidLevothyroxine Sodium | 217 | $19,481 |
| JanuviaSitagliptin Phosphate | 11 | $14,949 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $14,329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $445 | $263,879155 claims |
| PfizerEliquis | $267 | $112,861125 claims |
| Johnson & JohnsonXarelto | $46 | $93,20292 claims |
| Lilly USA, LLCMounjaro, Trulicity | $168 | $79,69666 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere, Symbicort | $254 | $76,17696 claims |
| Boehringer IngelheimJardiance, Glyxambi | $67 | $54,19544 claims |
| AbbVieLinzess, Synthroid | $187 | $41,928232 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $159 | $37,68559 claims |
| Astellas Pharma US IncMyrbetriq | $19 | $28,37740 claims |
| MerckJanuvia | $11 | $14,94911 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $153 | $9,82215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Hendersonville
- David LamondHendersonville$169K
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.